
Tuesday, July 01, 2025 12:55:51 AM
How does this early trial announced days before their acquisition compare FT819 prospects? I have rarely seen M&A so early in pre-clinical/Ph1. FATE seems to have received favorable sentiment after this news. I appreciate your insight as your scientific intuition is far beyond my understanding.
https://news.abbvie.com/2025-06-30-AbbVie-to-Acquire-Capstan-Therapeutics,-Further-Strengthening-Commitment-to-Transforming-Patient-Care-in-Immunology
Recent FATE News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/03/2025 08:03:21 PM
- Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/03/2025 05:05:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 06/17/2025 08:01:20 PM
- Fate Therapeutics Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis at EULAR 2025 Congress • GlobeNewswire Inc. • 06/11/2025 01:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/04/2025 08:02:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2025 10:55:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2025 09:15:02 PM
- Fate Therapeutics Appoints Matthew Abernethy, M.B.A., to its Board of Directors • GlobeNewswire Inc. • 05/30/2025 08:30:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2025 08:09:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2025 08:09:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2025 08:08:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2025 08:06:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2025 08:05:37 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2025 08:01:13 PM
- Fate Therapeutics Announces Phase 1 Data Presentation of FT819 Off-the-Shelf CAR T-cell Product Candidate for SLE at EULAR 2025 Congress • GlobeNewswire Inc. • 05/28/2025 09:54:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 08:03:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2025 08:02:25 PM
- Fate Therapeutics Reports First Quarter 2025 Financial Results and Business Updates • GlobeNewswire Inc. • 05/13/2025 08:01:00 PM
- Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/02/2025 08:01:00 PM
- Fate Therapeutics Announces Five Presentations on Off-the-Shelf CAR T-cell Product Platform at ASGCT Annual Meeting • GlobeNewswire Inc. • 04/29/2025 01:25:39 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/24/2025 12:39:15 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/17/2025 08:07:31 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/17/2025 08:05:27 PM
- Fate Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for FT819 to Treat Moderate to Severe Systemic Lupus Erythematosus (SLE) • GlobeNewswire Inc. • 04/14/2025 12:00:00 PM
FEATURED Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM
VAYK Discloses More Insider Buying Approaching 15 Million • VAYK • Jul 2, 2025 10:37 AM
Patented, Groundbreaking Blockchain for Public Companies 'BlackStar Digital Trading PlatformTM' can Facilitate U.S. Registered Securities to Trade on Blockchain Without Tokens. • BEGI • Jul 1, 2025 12:54 PM
UC Asset (UCASU) Public Offering's Acquisition Target Reported Better Results • UCASU • Jul 1, 2025 9:15 AM